Sionna Therapeutics

Boston, MA

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Company Details

Founded: 2018
Employees: Between 10 - 50 employees
Raised: $292,000,000
Headquarters Location: Boston, MA
Public: Yes
Acquired: No
CEO: Mike Cloonan
Founders: Mark Munson
Greg Hurlbut

Company Collections

These are collections Sionna Therapeutics is a part of. Click on the collection name to view similar companies.

Sionna Therapeutics' Industries

Medical Organizations

Biotechnology Companies

Sionna Therapeutics' Tech Stack